Precision medicine software maker Syapse raises $25M
The precision medicine company can meld treatment data with complex EHR records - and raised $25 million to expand its capabilities.
Syapse and Caris Life Sciences to profile up to 100,000 cancer patients each year in huge precision medicine effort
Syapse and Caris Life Sciences are combining molecular and genomics data with patient medical record information of up to 100,000 cancer patients each year to build out a huge clinical decision-making tool.
presented by
Transforming Patient Care: The Role of AI-Powered Assistants
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
UCSF’s one-size-fits-all precision medicine test for infection
What pathogen is causing a patient's disease? A coalition of University of California researchers, doctors and Silicon Valley companies are working together to create a test that can diagnose whether a severely ill patient has a virus, bacteria, fungus or parasite.
Health IT company that helps make sense of genomics data raises $10M
Syapse, a healthcare data analytics company that helps health systems crunch and analyze genomics data and clinical data to support treatment decisions has closed a Series B round. It will go toward expanding the company’s sales and marketing muscle and advance clinical development. Safeguard Scientifics led the $10 million Series B round, and […]